ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,873Medicare Part D Prescriptions Filled, Including Refills

Rank: 186 out of 1499

$656K Total Retail Price of All Prescriptions

Rank: 194 out of 1499

349 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 8,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 427 276 1 1
OMEPRAZOLE 408 213 2 5
POTASSIUM CHLORIDE 377 294 3 11
HYDROCODONE-ACETAMINOPHEN 331 197 S3 4 4
SIMVASTATIN 324 166 5 3
FUROSEMIDE 320 277 6 7
LEVOTHYROXINE SODIUM 314 197 7 2
METFORMIN HCL 290 185 8 8
TRAMADOL HCL 242 165 9 16
RANITIDINE HCL 235 133 10 15
ZOLPIDEM TARTRATE 208 146 11 23
AMLODIPINE BESYLATE 208 139 11 6
METOPROLOL TARTRATE 208 133 11 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 199 158 14 25
ISOSORBIDE MONONITRATE ER 192 110 15 51
WARFARIN SODIUM 177 160 16 12
CLOPIDOGREL 170 131 17 39
HYDROCHLOROTHIAZIDE 167 116 18 9
ENDOCET 159 73 S2 19 111
DOXAZOSIN MESYLATE 146 110 20 104
GABAPENTIN 140 54 21 13
PLAVIX 133 111 22 54
CRESTOR 119 89 23 34
CARVEDILOL 114 92 24 22
TRAZODONE HCL 109 67 25 32
DIGOXIN 108 85 26 56
NEXIUM 105 45 27 28
LANTUS 103 90 28 46
ADVAIR DISKUS 102 58 29 37
CYCLOBENZAPRINE HCL 102 44 R 29 41
PROAIR HFA 101 58 31 30
BISOPROLOL-HYDROCHLOROTHIAZIDE 100 42 32 169
CARISOPRODOL 97 19 R 33 71
AZITHROMYCIN 95 65 34 45
METOCLOPRAMIDE HCL 91 48 35 114
BUSPIRONE HCL 89 71 36 94
ATORVASTATIN CALCIUM 89 64 36 17
COMBIVENT 88 42 38 78
CLONIDINE HCL 86 71 39 57
PHENYTOIN SODIUM EXTENDED 85 20 40 137
METOPROLOL SUCCINATE 84 63 41 20
GLIPIZIDE XL 84 67 41 164
CITALOPRAM HBR 84 61 41 14
ATENOLOL 81 46 44 21
KLOR-CON M20 78 55 45 97
ALLOPURINOL 77 67 46 36
JANUVIA 73 46 47 84
SPIRIVA 70 48 48 44
FAMOTIDINE 67 58 49 86
TAMSULOSIN HCL 67 49 49 29
DIOVAN 65 62 51 58
LOSARTAN POTASSIUM 65 65 51 26
SERTRALINE HCL 63 21 53 24
FENTANYL 62 48 S2 54 60
PRAVASTATIN SODIUM 60 38 55 18
LIDODERM 59 41 56 123
AMITRIPTYLINE HCL 57 44 R 57 49
CYMBALTA 56 20 58 40
DONEPEZIL HCL 55 46 59 35
GLIPIZIDE 55 33 59 64
NOVOLOG 53 44 61 110
INSULIN SYRINGE 52 37 62 102
VERAPAMIL ER 52 52 62 117
SINGULAIR 51 17 64 67
TRICOR 50 27 65 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.